Adenosine receptor expression in a rat model of experimental autoimmune myasthenia gravis

Cell Immunol. 2014 Aug;290(2):217-25. doi: 10.1016/j.cellimm.2014.07.005. Epub 2014 Jul 21.

Abstract

Extracellular adenosine is an essential negative regulator of immune reactions that acts by signaling via 4 distinct adenosine receptors. We evaluated adenosine receptor expression in Lewis rats presenting with experimental autoimmune myasthenia gravis (EAMG) to determine whether the expression of adenosine receptors are changed in the development and progression of EAMG. Lymphocyte A1AR and A2AAR mRNA and protein levels from lymphocytes harvested from the lymph nodes, spleen, and peripheral blood mononuclear cells (PBMCs) of EAMG rats were decreased. A modest but not significant increase in A2BAR levels was observed in EAMG lymphocytes harvested from lymph nodes and PBMCs. No changes in A3AR expression were observed in lymphocytes harvested from lymph nodes, spleen, or PBMCs following EAMG induction. Results presented in this report showed that the expression levels and the distribution pattern of adenosine receptors were altered in EAMG lymphocytes.

Keywords: AChR; Adenosine receptor; Autoimmune disease; EAMG.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Autoantibodies / blood
  • Autoantibodies / immunology
  • Blotting, Western
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Flow Cytometry
  • Myasthenia Gravis, Autoimmune, Experimental / immunology*
  • Myasthenia Gravis, Autoimmune, Experimental / metabolism*
  • Rats
  • Rats, Inbred Lew
  • Real-Time Polymerase Chain Reaction
  • Receptors, Purinergic P1 / biosynthesis*
  • Receptors, Purinergic P1 / immunology

Substances

  • Autoantibodies
  • Receptors, Purinergic P1